[The combination sulfamethoxazole-trimethoprim in vitro].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D008722:Methods; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D013420:Sulfamethoxazole / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole
Die Kombination Sulfamethoxazol-Trimethoprim in vitro.